Advertisement
YOU ARE HERE: LAT HomeCollectionsSandoz
IN THE NEWS

Sandoz

FEATURED ARTICLES
NEWS
October 28, 2010 | By Andrew Zajac, Los Angeles Times
German drug maker Sandoz on Thursday announced a recall of two sizes of methotrexate injection vials sold under the Sandoz and Parenta brands because of the possible presence of glass flakes. "While it is unlikely," injection of the drug from affected vials "could lead to serious adverse events, resulting in disability and death," Sandoz said in a statement, which also recommended that patients immediately stop use of the affected product. The flakes resulted from delamination of glass used to make the 50 mg and 250 mg vials of the drug.
ARTICLES BY DATE
NEWS
October 28, 2010 | By Andrew Zajac, Los Angeles Times
German drug maker Sandoz on Thursday announced a recall of two sizes of methotrexate injection vials sold under the Sandoz and Parenta brands because of the possible presence of glass flakes. "While it is unlikely," injection of the drug from affected vials "could lead to serious adverse events, resulting in disability and death," Sandoz said in a statement, which also recommended that patients immediately stop use of the affected product. The flakes resulted from delamination of glass used to make the 50 mg and 250 mg vials of the drug.
Advertisement
BUSINESS
July 24, 2010 | By Andrew Zajac, Tribune Washington Bureau
In a closely watched decision, the Food and Drug Administration on Friday approved an application by German drug maker Sandoz and Momenta Pharmaceuticals Inc. of Cambridge, Mass., to make the first generic version of the widely used blood thinner Lovenox. The approval positions Momenta and Sandoz to offer a cheaper but still lucrative alternative to Lovenox, which had sales of $4.5 billion in 2009, making it the 15th-bestselling drug in the world. In its decision, the FDA also rejected an argument by Lovenox's maker, Sanofi-Aventis, that its drug, which is made from sugar molecules found in heparin, a substance derived from pig intestines, is too complex to be copied with precision by makers of generic versions of the medication.
BUSINESS
July 24, 2010 | By Andrew Zajac, Tribune Washington Bureau
In a closely watched decision, the Food and Drug Administration on Friday approved an application by German drug maker Sandoz and Momenta Pharmaceuticals Inc. of Cambridge, Mass., to make the first generic version of the widely used blood thinner Lovenox. The approval positions Momenta and Sandoz to offer a cheaper but still lucrative alternative to Lovenox, which had sales of $4.5 billion in 2009, making it the 15th-bestselling drug in the world. In its decision, the FDA also rejected an argument by Lovenox's maker, Sanofi-Aventis, that its drug, which is made from sugar molecules found in heparin, a substance derived from pig intestines, is too complex to be copied with precision by makers of generic versions of the medication.
BUSINESS
January 4, 2009 | Times Wire Reports
Johnson & Johnson said it was voluntarily recalling some skin patches containing the pain medicine fentanyl because of possible cuts in the reservoir containing the drug that could make it possible for patients to overdose. The Duragesic-brand patch is made by Alza Corp., a Mountain View, Calif., company owned by Johnson & Johnson. Some of the patches are sold without the Duragesic brand by Sandoz Inc. The lot number for the Duragesic patches is 0817239, and the lot number for the Sandoz patches is 0816851.
NEWS
November 16, 1986 | From Times Wire Services
Authorities Saturday lifted the last water pollution alerts that were posted when an estimated 30 tons of chemical poisons were dumped into the Rhine River. The water pollution alerts were called off for two towns in the Rhine Palatinate. They already had been lifted for the states of Baden-Wuerttemberg and North Rhine-Westphalia.
NEWS
January 14, 1993
School: Pius X Sport: Basketball Position: Forward Class: Senior The Warriors forward had 95 points and 50 rebounds in three Del Rey League victories. Sandoz began the week with 29 points and 15 rebounds in a 50-48 victory over St. Anthony. She had 30 points and 16 rebounds in a 60-37 victory over St. Joseph, and capped that with a 36-point, 19-rebound performance in a 69-56 victory over St. Paul. It is the second time this season that Sandoz has been named girls' athlete of the week.
SPORTS
April 30, 1993
Sherise Sandoz, a forward from Downey Pius X High, has signed with UC Irvine, women's basketball Coach Colleen Matsuhara announced Thursday. Sandoz, 5-feet-8, averaged 25.4 points and 15.9 rebounds last season.
BUSINESS
December 18, 1996 | Times Staff and Wire Reports
The Federal Trade Commission conditionally approved the merger of Swiss drug giants Ciba-Geigy and Sandoz, a deal that would create the world's second-largest drug company, Novartis. The agency said it would require a record $1-billion-plus in divestitures and licensing to preserve competition in key areas. The agreement seeks to ensure a strong second player in the new field of gene therapy, a market the U.S. government estimates will mushroom to $45 billion by 2010.
SPORTS
January 11, 1994 | JOHN WEYLER
When Sherise Sandoz made her first appearance on campus, Coach Colleen Matsuhara worried that it might be her last. And some members of the women's basketball team were hoping she was right. Sandoz, who averaged 25 points and 16 rebounds last season at Downey Pius X High and was The Times' Southeast player of the year, also was considering Long Beach State and Hawaii when she arrived at Irvine for a recruiting visit. "She was kind of standoffish and we were puzzled," Matsuhara said.
BUSINESS
January 4, 2009 | Times Wire Reports
Johnson & Johnson said it was voluntarily recalling some skin patches containing the pain medicine fentanyl because of possible cuts in the reservoir containing the drug that could make it possible for patients to overdose. The Duragesic-brand patch is made by Alza Corp., a Mountain View, Calif., company owned by Johnson & Johnson. Some of the patches are sold without the Duragesic brand by Sandoz Inc. The lot number for the Duragesic patches is 0817239, and the lot number for the Sandoz patches is 0816851.
BUSINESS
December 18, 1996 | Times Staff and Wire Reports
The Federal Trade Commission conditionally approved the merger of Swiss drug giants Ciba-Geigy and Sandoz, a deal that would create the world's second-largest drug company, Novartis. The agency said it would require a record $1-billion-plus in divestitures and licensing to preserve competition in key areas. The agreement seeks to ensure a strong second player in the new field of gene therapy, a market the U.S. government estimates will mushroom to $45 billion by 2010.
BUSINESS
July 18, 1996 | From Bloomberg Business News
The European Commission approved a $36-billion union between Swiss drug makers Sandoz and Ciba-Geigy with only minor amendments. The commission, the executive agency of the European Union, gave the green light for the creation of Novartis after the two companies agreed to license out the production of methoprene, an ingredient used to make animal flea-control products.
BUSINESS
March 8, 1996 | CHRIS KRAUL, TIMES STAFF WRITER
Sandoz Ltd. and Ciba-Geigy Ltd. have already shown a keen interest in buying pieces of biotechnology companies, particularly in California. Their planned $27-billion merger should enable them to invest even more, at the same time spurring other drug giants to pursue further mega-mergers themselves, analysts said Thursday.
BUSINESS
August 19, 1994 | DAVID R. OLMOS, TIMES STAFF WRITER
Sandoz Pharmaceuticals said Thursday that it will stop selling its Parlodel drug for the purpose of suppressing lactose in women who have just given birth. Used widely for treating symptoms of Parkinson's disease and various endocrine disorders, Parlodel had been blamed in consumer lawsuits for fatal strokes and seizures in women who took it after giving birth.
CALIFORNIA | LOCAL
July 31, 1994 | DAVID FOSTER, ASSOCIATED PRESS
Forget spotted owls. To see where the debate over saving America's wildlife is heading, spend a day in the woods with ecologist David Shaw. Drive with him deep into the Olympic National Forest, hike through a grove of ancient firs, totter the length of a mossy log, and peer, finally, around the base of a dead tree to behold . . . the fuzzy sandoze. It's a fungus. A very odd fungus, with a fruiting body that's furry like a bear and sometimes as big, weighing up to 300 pounds.
CALIFORNIA | LOCAL
December 4, 1992 | GREG JOHNSON, TIMES STAFF WRITER
In one of the largest deals of its kind, Sandoz Pharmaceuticals Corp. has agreed to give La Jolla-based Scripps Research Institute $300 million in return for right of first refusal to Scripps' future medical discoveries. According to terms of the deal announced Thursday by Sandoz, the giant, New Jersey-based drug company will provide $300 million in research funding over a 10-year period beginning in 1997.
BUSINESS
March 8, 1996 | CHRIS KRAUL, TIMES STAFF WRITER
Sandoz Ltd. and Ciba-Geigy Ltd. have already shown a keen interest in buying pieces of biotechnology companies, particularly in California. Their planned $27-billion merger should enable them to invest even more, at the same time spurring other drug giants to pursue further mega-mergers themselves, analysts said Thursday.
BUSINESS
May 24, 1994 | JESUS SANCHEZ, TIMES STAFF WRITER
Baby food giant Gerber Products Co., whose foods have been a staple in American parents' cupboards for nearly 70 years, agreed Monday to be acquired by Swiss pharmaceuticals conglomerate Sandoz Corp. for $3.7 billion in cash. The deal would allow Gerber, which claims more than 70% of the large but stagnant U.S. baby food market, to seek faster growth overseas through Sandoz's international network of subsidiaries and distributors. Sandoz, in turn, would acquire a well-known U.S.
SPORTS
January 11, 1994 | JOHN WEYLER
When Sherise Sandoz made her first appearance on campus, Coach Colleen Matsuhara worried that it might be her last. And some members of the women's basketball team were hoping she was right. Sandoz, who averaged 25 points and 16 rebounds last season at Downey Pius X High and was The Times' Southeast player of the year, also was considering Long Beach State and Hawaii when she arrived at Irvine for a recruiting visit. "She was kind of standoffish and we were puzzled," Matsuhara said.
Los Angeles Times Articles
|